2021-11-16-世界卫生组织-Cervical_cancer_San_Marino_2021_country_profile_1页_52kb

Summary of San Marino Cervical Cancer Profile

Morbidity and Mortality

• Crude and age-standardized cervical cancer incidence rates are not available for 2020, and cumulative risk data are missing.
• Cervical cancer deaths and mortality-to-incidence ratio are not reported for the specified years.
• A population-based cancer registry exists (2021).

Primary Prevention

• HPV vaccination is implemented as a national program since 2008, targeting girls aged 11–14 years.
• Coverage among 9–14-year-old girls was 38% in 2020, with 30% of girls turning 15 in 2020 receiving their final dose.
• HPV is included in the national vaccination program, with geographical scale unspecified.
• Risk factors data unavailable: tobacco use prevalence, condom use, and HIV incidence are not reported.

Secondary Prevention Screening

• National cervical cancer screening program exists (2021), using primary screening tests like Pap smear.
• Targets women aged 26–65 years, with about 65% screened in the last five years.
• Of women aged 30–49 years, 81% have been screened with HPV test at some point, and early detection guidelines are available.

Treatment and Supportive Care

• National guidelines on cervical cancer management exist (2021).
• Data on radiotherapy and brachytherapy units are not available, along with details on medical staff numbers per 10,000 cancer patients.
• A referral system from primary to secondary and tertiary care exists, but specific details on facilities like cancer centers and radiation oncologists are not provided.

WHO Elimination Strategy

• San Marino has cervical cancer elimination targets for 2030, but progress data are not specified.